Cyclacel Pharmaceuticals, Inc. Key Financial Ratios and Statistics
Financial Ratios and Key Statistics FYE 31-Dec
| Profitability | 2007 | Leverage | 2007 |
| Net Inc/Comm Equity | -0.11 | Total Liab/Total Assets | 0.24 |
| Net Inc/Total Assets | -0.32 | Total Liab/Inv Cap | 0.29 |
| Net Inc/Inv Cap | -0.39 | Total Liab/Comm Equity | 0.08 |
| Pretax Inc/Net Sales | -202.28 | Interest Coverage Ratio | -116.01 |
| Net Inc/Net Sales | -186.46 | Curr Debt/Equity | NA |
| Cash Flow/Net Sales | -179.38 | LTD/Equity | NA |
| SG&A/NetSales | 89.48 | Total Debt/Equity | NA |
| Asset Utilization | Liquidity | ||
| Net Receivables Turnover | 0.05 | Quick Ratio | 4.32 |
| Inventory Turnover | NA | Current Ratio | 4.34 |
| Inventory Day Sales | NA | Net Rec/Curr Assets | 0.04 |
| Net Sales/Work Cap | 0.00 | Inv/Curr Assets | 0.00 |
| Net Sales/PP&E | 0.04 |
Cyclacel Pharmaceuticals, Inc. Key Financial Ratios and Statistics